Adriblastina RD

Adriblastina RD Contraindications

doxorubicin

Manufacturer:

Pfizer

Distributor:

Zuellig
Full Prescribing Info
Contraindications
Hypersensitivity to doxorubicin or any other component of the product (e.g., methyl p-hydroxybenzoate 1 mg, lactose monohydrate 50 mg), other anthracyclines or anthracenediones.
Intravenous (IV) use: persistent myelosuppression; severe hepatic impairment; severe myocardial insufficiency; recent myocardial infarction; severe arrhythmias; previous treatment with maximum cumulative doses of doxorubicin, daunorubicin, epirubicin, idarubicin, and/or other anthracyclines and anthracenediones (see Precautions).
Intravesical use: urinary infections; inflammation of the bladder; hematuria.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in